Akoya Biosciences (AKYA) Competitors $1.10 -0.09 (-7.56%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AKYA vs. AEHR, QSI, QTRX, FEIM, MASS, SEER, KEQU, NAUT, ODYS, and RPIDShould you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), Frequency Electronics (FEIM), 908 Devices (MASS), Seer (SEER), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), Odysight.Ai (ODYS), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry. Akoya Biosciences vs. Aehr Test Systems Quantum-Si Quanterix Frequency Electronics 908 Devices Seer Kewaunee Scientific Nautilus Biotechnology Odysight.Ai Rapid Micro Biosystems Aehr Test Systems (NASDAQ:AEHR) and Akoya Biosciences (NASDAQ:AKYA) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Which has stronger valuation & earnings, AEHR or AKYA? Aehr Test Systems has higher earnings, but lower revenue than Akoya Biosciences. Akoya Biosciences is trading at a lower price-to-earnings ratio than Aehr Test Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAehr Test Systems$61.48M3.96$33.16M$0.7810.51Akoya Biosciences$81.67M0.68-$63.32M-$1.13-0.99 Do insiders and institutionals hold more shares of AEHR or AKYA? 69.7% of Aehr Test Systems shares are held by institutional investors. Comparatively, 79.4% of Akoya Biosciences shares are held by institutional investors. 6.2% of Aehr Test Systems shares are held by company insiders. Comparatively, 7.3% of Akoya Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to AEHR or AKYA? In the previous week, Aehr Test Systems had 9 more articles in the media than Akoya Biosciences. MarketBeat recorded 18 mentions for Aehr Test Systems and 9 mentions for Akoya Biosciences. Aehr Test Systems' average media sentiment score of 0.47 beat Akoya Biosciences' score of 0.18 indicating that Aehr Test Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aehr Test Systems 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Akoya Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor AEHR or AKYA? Aehr Test Systems received 97 more outperform votes than Akoya Biosciences when rated by MarketBeat users. Likewise, 58.15% of users gave Aehr Test Systems an outperform vote while only 57.38% of users gave Akoya Biosciences an outperform vote. CompanyUnderperformOutperformAehr Test SystemsOutperform Votes13258.15% Underperform Votes9541.85% Akoya BiosciencesOutperform Votes3557.38% Underperform Votes2642.62% Is AEHR or AKYA more profitable? Aehr Test Systems has a net margin of 43.41% compared to Akoya Biosciences' net margin of -66.77%. Aehr Test Systems' return on equity of 21.09% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Aehr Test Systems43.41% 21.09% 18.08% Akoya Biosciences -66.77%-162.99%-32.76% Do analysts prefer AEHR or AKYA? Aehr Test Systems presently has a consensus price target of $25.00, suggesting a potential upside of 204.88%. Akoya Biosciences has a consensus price target of $3.49, suggesting a potential upside of 213.15%. Given Akoya Biosciences' higher probable upside, analysts clearly believe Akoya Biosciences is more favorable than Aehr Test Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aehr Test Systems 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Akoya Biosciences 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, AEHR or AKYA? Aehr Test Systems has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Akoya Biosciences has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. SummaryAehr Test Systems beats Akoya Biosciences on 14 of the 18 factors compared between the two stocks. Remove Ads Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKYA vs. The Competition Export to ExcelMetricAkoya BiosciencesAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.57M$4.01B$5.27B$7.29BDividend YieldN/A0.59%5.11%4.32%P/E Ratio-0.9423.0421.6417.60Price / Sales0.683.98370.8091.75Price / CashN/A36.1138.1534.64Price / Book1.011.726.353.91Net Income-$63.32M-$81.63M$3.20B$247.45M7 Day Performance-9.35%4.19%1.34%0.02%1 Month Performance-25.67%-6.16%-9.78%-7.53%1 Year Performance-71.98%-33.41%9.22%-0.82% Akoya Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKYAAkoya Biosciences2.2678 of 5 stars$1.10-7.6%$3.49+217.4%-70.3%$54.82M$81.67M-0.9390Analyst ForecastNews CoverageGap DownAEHRAehr Test Systems3.6775 of 5 stars$7.22-0.6%$25.00+246.3%-26.1%$214.52M$50.74M9.6390Analyst RevisionGap DownQSIQuantum-Si1.9803 of 5 stars$1.14+0.9%$3.48+204.8%-25.9%$208.78M$3.06M-1.78150Short Interest ↑Gap DownQTRXQuanterix2.3151 of 5 stars$5.17-13.0%$18.25+253.0%-68.7%$200.47M$135.44M-4.88460Short Interest ↑Positive NewsGap DownHigh Trading VolumeFEIMFrequency Electronics1.8519 of 5 stars$15.08+0.1%N/A+72.3%$145.93M$65.40M18.39200Short Interest ↑MASS908 Devices2.7241 of 5 stars$3.81flat$5.33+40.0%-23.1%$134.61M$59.63M-2.1560News CoverageGap DownSEERSeer1.6161 of 5 stars$1.79+4.7%$3.00+67.6%+17.3%$107.01M$13.95M-1.38160Gap DownKEQUKewaunee Scientific1.5348 of 5 stars$36.06+1.1%N/A-2.2%$102.95M$220.03M5.711,006Short Interest ↑Gap DownNAUTNautilus Biotechnology2.5666 of 5 stars$0.80+15.5%$2.42+200.5%-68.7%$101.44MN/A-1.44130Short Interest ↑Gap DownHigh Trading VolumeODYSOdysight.Ai1.3818 of 5 stars$6.06-2.1%$10.00+65.0%N/A$98.82M$3.96M-7.0540RPIDRapid Micro Biosystems1.4424 of 5 stars$2.05-6.4%$8.00+290.2%+134.1%$88.64M$28.05M-1.83200Short Interest ↑Gap Down Remove Ads Related Companies and Tools Related Companies AEHR Competitors QSI Competitors QTRX Competitors FEIM Competitors MASS Competitors SEER Competitors KEQU Competitors NAUT Competitors ODYS Competitors RPID Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AKYA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
